Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00068029
Status:
COMPLETED
Last Update Posted:
2008-04-07
First Post:
2003-09-04
Brief Title:
Pegvisomant And Sandostatin LAR Combination Study
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomized Parallel Group Three-Arm Study To Evaluate Treatment With A Combination Of Pegvisomant Plus Sandostatin Lar Pegvisomant Alone And Sandostatin Lar Alone In Patients With Acromegaly
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the safety and tolerability of combination therapy with Sandostatin LAR plus Pegvisomant to that of Sandostatin LAR alone or Pegvisomant alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A6291006 | None | None | None |